Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Lyra Therapeutics Inc. logo

Lyra Therapeutics Inc.

Sector: Manufacturing   

Industry: Surgical and Medical Instrument Manufacturing

6.53
 
USD
  
0.40
  
(6.53%)
Optionable: No  Market Cap: 366 M  90-day average vol: 295,481

Previous close: 6.13  Open: 6.16  Bid: 6.48  Ask: 6.8
52 week range    
1.91   
   6.79
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 28th March 2024
58
MarketXLS Rank
60
Value
76
Technical
39
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

LYRA Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22
AccretionOnPreferredStock115000.0
Basic EPS from continuing operations-2.59-3.35-1.83
Basic EPS total-2.59-3.35-1.83
Basic weighted shares outstanding9 M13 M30 M
Depreciation100000.01000000.01 M
DepreciationAndAmortization100000.01000000.01 M
Diluted EPS total-2.59-3.35-1.83
Diluted normalized net income/share-1.83
Diluted weighted shares outstanding9 M30 M
GeneralAndAdministrativeExpense10 M14 M18 M
Gross operating profit285000.01 M
Income before tax-22 M-44 M-55 M
Income taxes13000.0
Interest income82000.0102000.01 M
Net income from total operations-22 M-43 M-55 M
NetIncomeCommonStockholders-22 M-44 M-55 M
NetIncomeContinuousOperations-22 M-43 M-55 M
NetNonOperatingInterestIncomeExpense82000.0102000.01 M
Normalized income-34 M-42 M
Operating income-22 M-44 M-56 M
Operating income before depreciation (EBITDA)-22 M-43 M-55 M
OperatingExpense22 M44 M58 M
Other income net1 M
OtherGandA10 M14 M18 M
OtherImpairmentOfCapitalAssets1 M
OtherOperatingExpenses2 M6 M5 M
OtherunderPreferredStockDividend115000.0
PreferredStockDividends115000.0
Research & development expense13 M30 M39 M
ResearchExpense13 M30 M39 M
Selling Gen & administrative expense10 M14 M18 M
Total Income available for interest expense (EBIT)-22 M-44 M-55 M
Total common shares outstanding13 M13 M32 M
Total net income-22 M-43 M-55 M
Total ordinary shares53 M53 M53 M
Total revenues285000.01 M
TotalExpenses22 M44 M58 M
TotalRevenue285000.01 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University